Pacira BioSciences Inc
PCRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.45B
Close$
$58.75
61.5% upside
Current Fair Value
61.5% upsideUndervalued by 61.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.45 Billion |
|---|---|
| Enterprise Value | $1.66 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.16 |
| Beta | 0.25 |
| Outstanding Shares | 39,462,000 |
Return
| Return on Equity | 6.94% |
|---|---|
| Return on Assets | 3.75% |
| Return on Invested Capital | 1.96% |
Valuation & Multiples
| P/E Ratio | 103.44 |
|---|---|
| PEG | -52.77 |
| Price to Sales | 2.02 |
| Price to Book Ratio | 2.14 |
| Enterprise Value to Revenue | 2.22 |
| Enterprise Value to EBIT | 75.27 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.61 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.65
Average shareholder expectationRevenue Estimate
$191.06 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$0.73
Average shareholder expectationRevenue Estimate
$182.87 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 26.93% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.77%▼ 108.10% |
|---|---|
| Total Invested | $17.62M▼ 98.45% |
| Investors Holding | 37▼ 220.00% |
ESG Score
No data